Barclays’s SunLink Health Systems SSY Stock Holding History

Barclays’s Portfolio SSY Stock Details SSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4	Closed	–	–	7256
2019 Q1	$0	Buy	+4	New	+$5	﹤0.01%	7315

Other funds holding SSY

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPA

West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

Barclays's SSY Position: Q2 2019 in Review

Barclays sold out of SunLink Health Systems (SSY) in Q2 2019, closing a stake of 4 shares.

Barclays first reported a position in SSY in Q1 2019 and held it in 1 quarter. The position peaked at $0 in Q1 2019. 18 funds tracked by Wall St. Rank hold SSY as of Q2 2019.

Barclays reported no remaining SunLink Health Systems position as of Q2 2019 after selling out during the quarter.
Barclays sold 4 SunLink Health Systems shares in Q2 2019.
Barclays first reported a position in SunLink Health Systems in Q1 2019 and held it in 1 quarter.
Barclays's SunLink Health Systems position peaked at $0 in Q1 2019.
18 funds tracked by Wall St. Rank held SunLink Health Systems as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.